Skip to main content
Premium Trial:

Request an Annual Quote

Entelos Appoints New Chair, 3rd Millennium Gets an Incyte Exec, Agilent s Jeff White Moves to NaPro

NEW YORK, Oct. 9 - Agilent's Jeffrey White is joining NaPro BioTherapeutics as president of its genomics division, the firm said today.


He will direct the division's efforts to market genomic research tools, diagnostics, services, and therapeutics.


Previously, White was vice president and general manager of biochemistries and services for the life sciences and chemical-analysis group at Agilent, where he helped the company move into genomics and proteomics.


NaPro, based in Boulder, Colo., in-licenses and develops pharmaceuticals. It also is developing new genomic technologies.



Entelos has appointed former Protein Design Labs president Jon Saxe as board chair, the company said yesterday.


Saxe is executive-in-residence at the venture capital firm Institutional Venture Partners, and on the board of Incyte Genomics, among other companies. He was president at PDL from 1995 to 1999, and now sits on that company's board.


Entelos is based in Menlo Park, Calif. The company markets PhysioLab, a platform that simulates biological systems. It is available for use in drug discovery for metabolic, immunologic, and respiratory disorders and diseases.



Incyte Genomics' Juli Klemm has joined 3rd Millennium as senior project scientist, the company said yesterday.


Klemm will evaluate and recommend bioinformatics products for the company's clients.


She was previously director of scientific project management at Incyte, where she designed and implemented database and software projects and developed relational database schema.


3rd Millennium is based in

Cambridge, M ass.



Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kat McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics that runs every Wednesday.